U.S. Gas Utilities Stock News

NYSE:ENS
NYSE:ENSElectrical

EnerSys (ENS) Could Be 23% Undervalued As Greenville Plans Narrow

EnerSys (ENS) updated investors on its planned lithium cell manufacturing facility in Greenville, South Carolina, outlining a refined focus on aerospace, defense, and specialized industrial customers that require a secure U.S. based supply chain. See our latest analysis for EnerSys. The EnerSys share price has eased recently, with a 1 month share price return down 14.04% and a 3 month share price return down 7.38%, yet the year to date share price return of 26.55% alongside a 1 year total...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Stock And 2 Testing Companies In Focus After Cyclospora Outbreak

The recent Cyclospora outbreak has pushed food safety, traceability, and testing to the top of investors’ watchlists. When regulators, distributors, and restaurant suppliers come under pressure, attention often shifts to companies that help monitor, test, and verify what moves through the food supply chain. This article looks at how that news may affect a handful of Food Safety & Testing Companies, and why some stocks could be positioned as potential beneficiaries of higher scrutiny and...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Consumer Discretionary Stocks to Watch Before Earnings and the Fed Rate Decision

Consumer discretionary stocks are back in focus as markets react to falling oil prices, upcoming mega cap tech earnings, and the Federal Reserve’s next rate call. Lower fuel costs can reshape household budgets, while big tech results and policy signals may influence overall risk appetite. In addition, legal delays around the Paramount and Warner Bros. Discovery deal and new questions about AI rules are adding another layer of uncertainty. This article breaks down how these forces tie into...
NasdaqGS:PECO
NasdaqGS:PECORetail REITs

Stronger Q2 Earnings And Raised Guidance Could Be A Game Changer For Phillips Edison (PECO)

In July 2026, Phillips Edison & Company reported second-quarter revenue of US$189.62 million and net income of US$41.12 million, alongside higher earnings per share versus a year earlier, and raised its 2026 diluted net income guidance to US$0.95–US$0.97 per share from US$0.79–US$0.81. The combination of higher current-period profits and an upward revision to full-year earnings guidance highlights management’s increased confidence in the company’s operating performance. With this stronger...
NYSE:ATEN
NYSE:ATENSoftware

US Tech Stocks Retail Investors May Find More Sheltered From EU Rules And Tariffs

Renewed EU regulation and tariff threats are putting global tech stocks under a spotlight, while many US domestic focused technology companies sit slightly to one side of the crossfire. For investors sorting through the noise, the question is which stocks appear more insulated from these trade and regulatory headlines and which still carry meaningful exposure. This article examines how the latest EU actions and US tariff rhetoric could affect sentiment around certain US tech companies, and...
NYSE:GL
NYSE:GLInsurance

Do Globe Life’s (GL) Higher 2026 Earnings Guidance And Buybacks Reframe Its Capital Allocation Story?

Globe Life Inc. recently reported its second-quarter 2026 results, with higher revenue of US$1,599.73 million and net income of US$287.75 million, and subsequently raised its full‑year 2026 net operating earnings guidance to US$15.55–US$15.95 per diluted share, reflecting better life underwriting margins, excess investment income, and assumption‑related remeasurement gains. The company also continued its long-running capital return program by repurchasing 1,100,000 shares for US$175 million...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

Is Nektar Therapeutics (NKTR) Undervalued On Its Phase 3 Rezpegaldesleukin Launch?

Nektar Therapeutics (NKTR) has launched the first two global Phase 3 ZENITH AD trials for rezpegaldesleukin in moderate to severe atopic dermatitis, supported by earlier Phase 2b data and FDA Fast Track designations. See our latest analysis for Nektar Therapeutics. The latest rezpegaldesleukin Phase 3 launch comes after a sharp shift in sentiment around Nektar Therapeutics, with a 1-year total shareholder return of 199.05% and a year to date share price return of 62.89%. However, momentum has...
NYSE:QGEN
NYSE:QGENLife Sciences

Is Qiagen (QGEN) A Bargain On Its Infectious Disease Testing Push?

Qiagen (QGEN) is back in focus after highlighting its molecular testing tools in the U.S. cyclosporiasis response and launching a CE-IVDR-certified bloodstream infection and antimicrobial resistance panel for its QIAstat-Dx platform in Europe. See our latest analysis for Qiagen. Qiagen’s recent focus on infectious disease diagnostics comes as the stock trades at US$41.37, with a 90 day share price return of 21.6% but a year to date share price return that is down 13.03%, and a 1 year total...
NasdaqGS:EFSC
NasdaqGS:EFSCBanks

What Enterprise Financial Services (EFSC)'s Expanded Buyback and Dividend Amid Lower EPS Means For Shareholders

Enterprise Financial Services Corp has reported past second-quarter and six-month 2026 results showing higher net interest income but lower net income and earnings per share compared with a year earlier, alongside a quarterly dividend of US$0.35 per share payable on September 30, 2026. At the same time, the company completed a multi‑year share repurchase totaling 1,750,600 shares, expanded its buyback authorization to 4,000,000 shares, and continued distributing dividends, signaling a clear...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Gaming and Leisure Properties (GLPI) Following A Recent Share Price Move Is The Stock Cheap

Gaming and Leisure Properties (GLPI) is back on investor radars after a recent move in its share price, with the stock closing at $45.17. That shift has renewed interest in its underlying real estate fundamentals. See our latest analysis for Gaming and Leisure Properties. Over the past year, Gaming and Leisure Properties has paired a 5.77% total shareholder return with relatively muted share price moves. The recent 1-day share price return of 1.69% contrasts with a 90-day share price return...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Commvault Systems (CVLT) Nears Earnings, Is Slower Growth Already Priced In?

Commvault Systems (CVLT) is back in focus this week as the data protection software company prepares to report earnings before markets open on Tuesday, with investors watching a projected slowdown in revenue growth. See our latest analysis for Commvault Systems. At a share price of $142.31, Commvault Systems has posted a 45.24% 90 day share price return, yet the 1 year total shareholder return is down 12.92%. This indicates that recent momentum is improving compared with a weaker longer term...
NYSEAM:UMAC
NYSEAM:UMACElectronic

Can Unusual Machines’ (UMAC) Edge AI Drone Pivot Rebalance Its Government-Focused Investment Story?

Earlier this year, Unusual Machines, Inc. announced a collaboration with Lantronix Inc. to develop autonomous drone components that combine edge AI computing with flight control systems for the commercial drone market. This partnership could strengthen Unusual Machines’ position in higher-value drone technologies by pairing its hardware capabilities with Lantronix’s embedded computing and connectivity expertise. We’ll now examine how this edge AI and flight-control collaboration with...
NasdaqGS:HBT
NasdaqGS:HBTBanks

HBT Financial (HBT) Following Earnings Beat And Dividend Hike Looks Close To Fair Value

HBT Financial (HBT) is back on investors’ radar after reporting second quarter earnings that topped analyst estimates, alongside a higher quarterly dividend and continued share repurchases. See our latest analysis for HBT Financial. That backdrop of better than expected earnings, a higher dividend and ongoing buybacks sits alongside firm recent share price momentum, with a 16.24% 3 month share price return, 29.48% year to date share price return and a 33.98% 1 year total shareholder...
NYSE:RNR
NYSE:RNRInsurance

Is RenaissanceRe Holdings (RNR) Cheap Following AM Best's Rating Affirmation And Q2 Earnings?

RenaissanceRe Holdings (RNR) is back in focus after AM Best affirmed strong credit ratings with a positive and stable outlook, alongside second quarter results that showed revenue of US$2,768.6 million and net income of US$663.08 million. See our latest analysis for RenaissanceRe Holdings. The recent AM Best affirmation and the latest earnings release come on top of a strong run for RenaissanceRe Holdings, with a year to date share price return of 20.89% and a 1 year total shareholder return...
NYSE:SNA
NYSE:SNAMachinery

Snap On (SNA) Earnings Put Valuation Back In Focus As Upside Questions Build

Why Snap-on stock is back in focus after fresh earnings Snap-on (SNA) has moved back onto investor watchlists after reporting second quarter and year-to-date results that showed higher sales, net income, and earnings per share compared with the prior year. See our latest analysis for Snap-on. Alongside the latest earnings, Snap-on’s share price has gained 7.04% over the past 90 days and its 1-year total shareholder return of 27.17% and 5-year total shareholder return of 110.06% point to...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

Is T Mobile US (TMUS) Fairly Valued Following Earnings And Buybacks?

Q2 earnings and buybacks put T-Mobile US (TMUS) under the spotlight T-Mobile US (TMUS) has drawn investor attention after reporting second quarter 2026 results alongside an update on its ongoing share repurchase program, combining fresh earnings data with a clearer view of capital returns. For the quarter ended June 30, 2026, the company reported revenue of US$22,791 million compared with US$21,132 million a year earlier, while net income was US$3,239 million versus US$3,222 million in the...
NYSE:FCN
NYSE:FCNProfessional Services

FTI Consulting (FCN) Adds Senior Hires, Is The Stock Fairly Valued?

FTI Consulting (FCN) has drawn attention after appointing Dylan Ryan and Emmanuel Fages as Senior Managing Directors, moves that sharpen its focus on financial crime risk management and energy and utilities advisory work for global clients. See our latest analysis for FTI Consulting. FTI Consulting's latest executive hires arrive as the stock trades at $159.79, with a 1-day share price return of 1.49% and a 30-day share price return of 5.75%. This contrasts with a 1-year total shareholder...
NasdaqGS:WLTH
NasdaqGS:WLTHCapital Markets

Interest Rates Put These 3 Financial Stocks In Focus

With the Federal Reserve sitting on a knife edge between holding rates and a possible 25 basis point hike, interest rate expectations, bond yields, and renewed Middle East tensions are back in the spotlight for banking and financial stocks. Higher oil prices and mixed inflation signals are feeding fresh volatility into funding costs and loan demand, while two year Treasury yields around 4% keep rate hike odds alive. This article looks at three large, financially healthy stocks from our...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

ICON (ICLR) Rebound Puts Its Valuation Story Back In Focus

ICON (NasdaqGS:ICLR) has drawn investor attention after recent share performance data highlighted a mix of short term declines and longer term gains, which has prompted a closer look at how the clinical research company is currently valued. See our latest analysis for ICON. At a share price of $165.76, ICON’s recent pattern combines a sharp 90 day share price return of 61.73% with a decline of 12.60% in the 1 year total shareholder return. This suggests strong recent momentum following a...
NYSE:GPC
NYSE:GPCRetail Distributors

July 2026's Top Value Stocks Trading Below Estimated Worth

Over the last 7 days, the United States market has experienced a slight decline of 1.0%, although it has risen by 15% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this context, identifying stocks that are trading below their estimated worth can offer potential investment opportunities for those seeking value amidst fluctuating market conditions.
NasdaqGS:PTRN
NasdaqGS:PTRNMultiline Retail

Top Growth Companies With Insider Stakes July 2026

The United States market has shown resilience with a 15% increase over the past year, despite a recent 1.0% dip in the last week, and earnings are projected to grow by 17% annually in the coming years. In this environment, growth companies with substantial insider ownership can be particularly appealing as they often indicate confidence from those closest to the business operations and strategy.
NasdaqGM:NA
NasdaqGM:NASemiconductor

Discovering Nano Labs And Two Other Promising Penny Stocks

Over the last 7 days, the U.S. market has dropped 1.0%, but it remains up 15% over the past year with earnings forecast to grow by 17% annually. In light of these conditions, identifying stocks with strong financial health and growth potential becomes crucial for investors seeking opportunities beyond traditional investments. Penny stocks, though a somewhat outdated term, still represent a relevant investment area where smaller or newer companies can offer significant returns when backed by...
NYSE:RYN
NYSE:RYNSpecialized REITs

Eagle Financial Services And 2 More Top Dividend Stocks To Consider

Over the last 7 days, the United States market has experienced a slight decline of 1.0%, although it has seen an impressive rise of 15% over the past year, with earnings projected to grow by 17% annually. In this context, selecting dividend stocks like Eagle Financial Services can be a strategic choice for investors seeking stable income and potential growth amidst fluctuating market conditions.
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Charles Schwab Stock And 2 Bond Names for Short Term Rate Risk

Rising concerns about U.S. government debt and interest rate risk are pushing many investors to rethink how they use bonds, especially long-term Treasuries. With Jamie Dimon openly cautioning against locking into long maturities, attention is shifting toward short-term bond products and the companies that issue or distribute them. Some stocks could benefit from stronger flows into ultra short-term bond ETFs, while others tied more closely to long-duration products may face tougher questions...